News

A note from our CEO: Rohan Greenland – May

18 May 2021

May is a significant month for the entire MS community, both here in Australia and around the globe. With World MS Day on May 30, we have a month of important activities ahead.

Our major annual fundraising event for MS research is underway – The May 50K – and it’s off to a terrific start with almost 30,000 Australians registered to take part and over $3 million received in donations so far. There’s still time to sign up or sponsor a participant and help us leave MS where it belongs, behind us! To find out more information about The May 50K, click here.

We have also worked closely with the MS community to develop a new animation: Connecting with Family and Friends. This reflects the global World MS Day 2021 theme of ‘Connections’, which aims to challenge social barriers that can leave people living with MS feeling lonely and isolated.

Additionally on May 25, MS Australia will be hosting a Parliamentary Friends of MS event, which will spotlight the latest research and advocacy developments, live-streamed from Parliament House, Canberra. The event will be addressed by the people living with MS, Members of Parliament and leading MS researchers, as well as our MS Australia President, Associate Professor Des Graham. To find out more about this event, and the other World MS Day events happening across the country and globally, please click here.

Finally, an enormous thank you to all who are supporting our fundraising efforts – your support is critical to driving the great advances achieved through research.

Related News

30 July 2025

MS Australia announces the four recipients of the first round of Incubator Grants for 2025….

30 July 2025

A world-first Australian study is using DNA to identify a person’s genetic risk of developing multiple sclerosis (MS) to understand…

29 July 2025

MS Australia is calling on the government to improve the aged care system to better meet the needs of older…

29 July 2025

CEO Rohan Greenland reveals the upcoming launch of a national blueprint for neurological conditions, designed to prompt the Australian Government…

29 July 2025

Consistently high antibodies to a specific protein of the Epstein-Barr virus may predict MS years before disease onset….

26 June 2025

The Pharmaceutical Benefits Advisory Committee has recommended ublituximab (Briumvi®) be listed on the PBS for treating relapsing remitting MS….
Read More
connie-bakerbrain-scan progressive MS

Newsletter subscription

  • Enter your details

A note from our CEO: Rohan Greenland – May